Menu 返回Speakers

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing


讲演嘉宾

  • Anne  Arvizu, PharmD

    Anne Arvizu, PharmD

    • Chief Executive Officer and Medical Affairs Advisor
    • RxER Communications Corp, United States

    Dr. Anne Arvizu is founder and CEO of RxER Communications Corp (www.rxercommunications.com). With 22 years of executive leadership experience in the pharma/biotech industry, she has served in key roles such as Head of Global Med Info, Knowledge Mgmt. and Literature Surveillance for Baxter, Baxalta & Shire; Member Executive, PhactMI; International Regional Head & Director of Med Comm/Med Info for GSK, LATAM; DIA MASC Program Committee & Track Chair; Podcast Host for ACMA (#V3Podcast); Board Member of AMWA and serves as Chair, South Florida YMCA Board of Directors. She currently engages biotech C-Suite and VP Level executive clients as an expert consultant for Medical Affairs Capabilities build, renovation, and value-based business expansion.

  • Dan  Benau, PhD

    Dan Benau, PhD

    • Director, Biomedical Writing Programs
    • University of the Sciences, United States

    Dan Benau, PhD, Director of Biomedical Writing Programs at the University of the Sciences. Scientific Writer - Principal Medical Writer (1991 - 2001), Wyeth-Ayerst Research, Medical Writing Project Leader (2001 - 2003), Sanofi-Synthelabo , Freelance (2003 - 2008), Director of BW Programs (2008 - present). DIA Professional Education, Development, Training Community (2004 - 2016), DIA Medical Writing Community (2003 - present).

  • Ivy Lee Chang, PharmD

    Ivy Lee Chang, PharmD

    • Principal Medical Science Director, Medical Affairs
    • Genentech, Inc., A Member of the Roche Group, United States

    Ivy has 18+ years of experience in the pharmaceutical industry. She is an Associate Director in Medical Communications at Genentech with experience across diverse therapeutic areas including Oncology, Rheumatology, Respiratory, Ophthalmology, Endocrinology, Neurology, Cardiovascular Disease, and various clinical conditions with an immunologic basis in pathophysiology. Prior to joining Genentech, she was a Clinical Pharmacist in General Surgery, Surgical Subspecialties, and Solid Organ Transplant at the University of California San Francisco (UCSF) Medical Center, and an Assistant Clinical Professor with the UCSF School of Pharmacy.

  • Ruggero  Galici, PhD

    Ruggero Galici, PhD

    • Associate Director, Medical Writing
    • Pfizer Inc, United States

    Dr. Galici has a background in Drug Discovery and Clinical Development with expertise in pharmacology and medical writing. He has a track record of successfully and strategically planning and delivering scientific, medical communications and regulatory submissions.

  • Jennie  Jacobson, PhD

    Jennie Jacobson, PhD

    • Medical Writing & Scientific Services, Lead Medical Writer
    • Syneos Health, United States

    Jennie G. Jacobson is a Lead Medical Writer at Fishawack Communications where she specializes in publications. Jennie earned a BA from Swarthmore College, and a PhD from Harvard University. She conducted post-doctoral research at Upjohn Laboratories and the University of Michigan before realizing that medical writing would allow her all the fun of interpreting the data without the work of generating the data. She rounded out her education with two AMWA certifications and a certificate in Medical Writing from the University of Chicago. In her 19 years as a medical writer, Jennie has worked in mental health, health outcomes research, infectious disease, endocrinology and respiratory disease.

  • Taleen  Kalebjian, PharmD

    Taleen Kalebjian, PharmD

    • Senior Manager, Medical Information
    • Gilead Sciences, Inc., United States

    Taleen is currently the US lead for HIV Medical Information at Gilead Sciences. After graduating from USC School of Pharmacy she pursued a career in retail pharmacy, which provided experience in a variety of settings including management. She later had the opportunity to switch paths and move into the pharmaceutical industry at Gilead, where she has supported the cardiovascular, cardiopulmonary, and HIV portfolios.

  • Stephanie  Krupski

    Stephanie Krupski

    • Consultant - Global Scientific Communications
    • Eli Lilly and Company, United States

    I am a Global Scientific Communications Consultant – Regulatory Lead at Eli Lilly and Company. As a regulatory lead, I am responsible for leading submission (and other regulatory writing) teams by working cross-functionally with multidisciplinary groups across multiple geographies and phases of drug development. Prior to Lilly, I completed a PhD at University of Cincinnati, studying gastrointestinal hormone secretion, and a post-doctoral fellowship at the IU School of Medicine, studying insulin secretion. Outside of work, I love to read, mentor youth at my church, and work on my new lake house.

  • Andrea  Meyers

    Andrea Meyers

    • Vice President, Medical Writing
    • Syneos Health, United States

    Ms. Meyers is the Vice President of Medical Writing at Syneos Health. She has led global medical writing teams for more than two decades in both CRO and sponsor organizations. Ms. Meyers has authored documents across all phases of clinical development for pharmaceutical products as well medical devices, including regulatory dossiers and submissions. In addition, she has also led regulatory and clinical development, leading two oncology products to NDA submission and subsequent approval. Prior to her career in clinical research, Ms. Meyers practiced neuropsychology.

  • Robert  Paarlberg, MS, MSc

    Robert Paarlberg, MS, MSc

    • Principal
    • Paarlberg & Associates LLC, United States

    Robert Paarlberg is the Principal of Paarlberg & Associates LLC, a consultancy specializing in regulatory policy, regulatory intelligence and global clinical trial disclosure strategy and operations. Prior to founding Paarlberg & Associates LLC, Bob created and directed global regulatory policy and intelligence functions at UCB and Pharmacia (Upjohn). Bob is past Chair of DIA’s Clinical Trial Disclosure Community. Bob has more than 35 years of pharmaceutical industry experience with the vast majority of his experience in US and international regulatory affairs.

  • Amy  Van Sant, PharmD, MBA

    Amy Van Sant, PharmD, MBA

    • President, Medical Affairs
    • Ashfield Healthcare LLC, United States

    Amy is the current President of Ashfield's US Medical Affairs business unit, which includes the departments of Medical Information, Pharmacovigilance, and Medical Science Liaisons. In this role, she is responsible for developing, communicating and driving organizational strategy and leading her organization to success. With over 15 years of experience in the healthcare and biopharmaceutical industry, she has held various roles of increasing responsibility within the areas of Regulatory and Medical Information. Prior to joining Ashfield, Amy supported several key therapeutic areas within the Pharmaceutical Companies of Johnson & Johnson as Director, Regulatory Advertising and Promotion.

  • Donna  Booth, PharmD

    Donna Booth, PharmD

    • Senior Director, US VEO Strategic Initiatives Lead
    • GlaxoSmithKline, United States

    Donna V. Booth, B.S, PharmD. is a Senior Director within Value Evidence & Outcomes team at GlaxoSmithKline. She has extensive experience across Medical Affairs as Medical Information leader aligned to various therapeutic areas as well as Payers and Policymakers; as Health Policy Liaison focused on Healthcare Quality; and she is currently focused on strategic initiatives that drive the efficiency, effectiveness, and acceptability of health economics and outcomes evidence. Donna received a Bachelor of Pharmacy from the University of Georgia and a Doctor of Pharmacy from the Medical University of South Carolina. Before joining industry, Donna was a clinical pharmacist with faculty appointments at local colleges of pharmacy.

  • Poonam A. Bordoloi, PharmD

    Poonam A. Bordoloi, PharmD

    • Director, Medical Affairs Team Lead
    • Merck & Co., Inc., United States

    Poonam is currently a Team Lead within the Global Scientific Content group at Merck based in Kenilworth, NJ. Most recently Poonam was at Celgene in the Strategic Medical Communications and Innovation group. Prior to joining Celgene, Poonam worked at Sanofi in the Medical Information Services Department for 12 years, at Johnson and Johnson in the Global Competitive Intelligence group for 3 years, and at Parke-Davis in the Medical Information Department for 3 years. She has over 22 years of experience in the Medical Information setting and has 2 publications regarding Social Media and Medical Information Trends. Poonam is actively involved in DIA and is co-chairing the 2019 DIA MASC meeting.

  • Jennifer  Brea

    Jennifer Brea

    • Independent Documentary Filmmaker
    • Canada

    Jennifer Brea is an independent documentary filmmaker based in Los Angeles. She has an AB from Princeton University and was a PhD student at Harvard until sudden illness left her bedridden. In the aftermath, she rediscovered her first love, film. Her feature documentary, Unrest, premiered at the Sundance Film Festival in January 2017, where it won a Special Jury Prize. She is also co-creator of Unrest VR, winner of the Sheffield Doc/Fest Alternate Realities Award. An activist for invisible disabilities and chronic illness, she co-founded a global advocacy network, #MEAction and is a TED Talker.

  • Ed  Cunningham, PharmD

    Ed Cunningham, PharmD

    • Senior Director, Neurology Medical Science Liaison Team Lead
    • Sunovion Pharmaceuticals, Inc., United States

    Ed Cunningham, PharmD is Senior Director, Neurology Medical Science Liaison (MSL) Lead at Sunovion Pharmaceuticals Inc. Ed is based in Milwaukee, WI, and is responsible for overseeing the US Neurology MSL team. Prior to Sunovion, Ed was the Director of Specialty Care MSLs at Eisai Inc., leading the company’s Neuroscience and Metabolic MSL teams. Ed obtained his PharmD degree from Philadelphia College of Pharmacy and completed a 1-year Drug Information Residency with Janssen Pharmaceutica. Ed has been in the pharmaceutical industry for over 15 years, working as both a direct contributor and a team leader in a variety of Medical Affairs functions, including Medical Information, Medical Education, Investigator Initiated Studies, and MSLs.

  • David  Meats

    David Meats

    • Associate Director, Global Submissions, PRW
    • Synchrogenix, United States

    David Meats is an Associate Director of Midwest Operations at Trilogy Writing and Consulting. David has been a medical writer for over 15 years, and is an expert in pharmaceutical regulatory writing. David is currently the co-chair for the 2019 DIA MASC meeting.

  • Sudip  Parikh, PhD

    Sudip Parikh, PhD

    • Senior Vice President and Managing Director, DIA Americas
    • DIA, United States

    Sudip S. Parikh, PhD, serves as Senior Vice President and Managing Director for DIA Americas. He previously served as Vice President and General Manager of Health & Consumer Solutions at Battelle, leading its Healthcare Improvement, Public Health Research, and Consumer, Industrial, and Medical Technology Development teams in R&D supported by government and commercial clients. Dr. Parikh is a board member of Research America, the Friends of Cancer Research, and the Food Innovation Center. He was a Presidential Management Fellow at the National Institutes of Health, and was awarded a National Science Foundation Graduate Research Fellowship while earning his PhD in Macromolecular Structure and Chemistry from The Scripps Research Institute

  • David  Price, PhD

    David Price, PhD

    • Advisor, US Bio-Medicines Medical Sciences Liaisons
    • Lilly USA, LLC, United States

    David Price, PhD has been employed with Eli Lilly and Company since 2011. Since joining the industry at Lilly, David has served as Medical Liaison supporting multiple therapeutic areas, including: Psychiatry, Urology and Musculoskeletal. In these roles, David developed and maintained TL relationships in the Midwest/Great Plains and Southwest/Mountain regions. In 2014, David joined Lilly’s Field Medical Operations team providing Strategy & Capabilities support for the US Medical Science Liaisons. David is currently a Global MSL Trainer for Eli Lilly and Company and works within The Office of Medical Professional Development.

  • Sarika  Sood, MD

    Sarika Sood, MD

    • Sr. Director Global Medical Information
    • Abbvie, United States

    Sarika Sood is the Head of AbbVie Global Medical Communications which includes Global Medical Information and Global Medical Publications. She has over 15 years of academic and pharmaceutical industry experience. Sarika has experience across many Medical Affairs capabilities including MSL leadership, Global Medical Information, Therapeutic Area Medical Teams. She has led and built teams at a global and local capacity. Sarika has had the opportunity to work in many therapeutic areas across the industry and enjoys being a strategic builder.

  • Robin L. Winter-Sperry, DrMed, MD

    Robin L. Winter-Sperry, DrMed, MD

    • Head, Global Field Based Medical Excellence
    • Sanofi Genzyme, United States

    Dr. Robin Winter-Sperry is currently the Head of Global Field Based Medical Excellence and Insights at Sanofi Genzyme based in Cambridge, MA, USA. Prior to joining Sanofi Genzyme in 2015, Robin was President of Scientific Advantage, a Medical Affairs consulting firm. While at Scientific Advantage, she was instrumental in Medical Affairs strategy and operations including mergers, transitions and Medical Affairs organizational design. Robin has pioneered the recognition of MSLs as a specialty in the biopharmaceutical and device industry and is responsible for creating and developing many of the industry’s leading Medical Affairs and Medical Liaison teams. To date, she has been involved in the commercialization and launch of over 28 products.

  • Ann  Winter-Vann, PhD

    Ann Winter-Vann, PhD

    • Senior Writer and Manager
    • Whitsell Innovations, Inc., United States

    Ann Winter-Vann earned her PhD in Molecular Cancer Biology from Duke University, where she was a predoctoral fellow of the Howard Hughes Medical Institute. Following a postdoctoral position in the Pharmacology Department at UNC-Chapel Hill, Ann joined Whitsell Innovations, Inc., where she is now a senior writer and manager. She has extensive experience in clinical regulatory writing and also provides consultations and training in medical writing. Ann has co-taught a science writing course for first-year biomedical graduate students at UNC-Chapel Hill. Ann is a past president of the Carolinas chapter and the current President-elect for the American Medical Writers Association (AMWA).

  • Deborah E. Collyar

    Deborah E. Collyar

    • President
    • Patient Advocates In Research (PAIR), United States

    Deborah Collyar has been a patient engagement leader since her first cancer diagnosis. She founded Patient Advocates in Research (PAIR) international communication network in 1996, "where research meets reality." Deborah infuses hundreds of patient advocates into research programs, and delivers innovative ways to gather input from thousands of patients. Her work encompasses many diseases, programs and policies at grassroots, national and international levels and emphasizes patient issues throughout development, clinical trials, and health literate communication with providers and patients. She is a speaker, blogger, author, team member, trainer, and faculty at professional workshops.

  • Robin  Whitsell

    Robin Whitsell

    • President
    • Whitsell Innovations, Inc., United States

    Founder and president of Whitsell Innovations, Inc., a medical writing firm headquartered in Chapel Hill, NC, she has 20 years’ experience, specializing in regulatory medical writing and submission strategies. Prior to founding WI, Ms. Whitsell was the assistant director of preclinical & clinical development at Inspire Pharmaceuticals and a team lead at GlaxoWellcome. She has degrees in biophysics and physics from Miami University and interned at Los Alamos National Laboratory.

  • Payal  Desai, PharmD

    Payal Desai, PharmD

    • Associate Director, Medical Information-CV
    • Janssen Scientific Affairs, LLC., United States

    Payal Desai earned a PharmD degree from the University of Sciences in Philadelphia. Dr. Desai worked in community practice before transitioning to a career in pharmaceutical industry. Over 20 years, Dr. Desai served at several pharmaceutical companies. In her current role at Janssen, she is the Associate Director of Medical Information, where she is responsible for the successful launch of cardiovascular products. She provides strategic medical support, develops internal education plan, and participates in several cross-functional teams. She has mentored several Post-doc Fellows and pharmacy students throughout her career.

  • Mark Alan DeWyngaert, PhD, MBA

    Mark Alan DeWyngaert, PhD, MBA

    • Advisory Managing Director
    • Deloitte, United States

    Dr. DeWyngaert trained as a molecular biologist and has been actively involved in both research and business development roles for over 30 years. He has provided operational, clinical, managerial, consulting, and litigation services to various segments of the health care industry. He specializes in assisting pharmaceutical manufacturers, biotechnology, and medical device companies with identifying and mitigating regulatory risks, valuing intellectual property and litigation support.

  • Jonathan  Edwards, MS

    Jonathan Edwards, MS

    • Medical Writer
    • Audubon PM Associates Inc., United Kingdom

    Over the course of 20 years working in the pharmaceutical industry, Jonathan has worked as a medical sales representative, a medical writer in an international medical communications agency, and for more than 10 years as a regulatory writer in a large pharmaceutical company. He set up an independent medical writing consultancy in 2015 as is based in the UK where his work focuses on delivery of regulatory submission packages.

  • Janet  Gottlieb

    Janet Gottlieb

    • Executive Director, Medical Communications
    • Allergan, Inc., United States

    Dr. Janet Gottlieb is the Executive Director of Medical Communications at Allergan, where she leads the team responsible for the medical review of Company advertising and promotional materials. At Allergan, she had a direct role in the formation, expansion, and training of the centralized team, which resulted in greater efficiencies via improved turnaround times, consistency in guidance, and enhanced communication. Dr. Gottlieb holds an undergraduate degree in Biological Sciences and Ph.D. in Medical Microbiology from the University of California, Irvine.

  • Bhakti  Kshatriya, PharmD

    Bhakti Kshatriya, PharmD

    • Founder, Publication Practice Counsel
    • Truposha, LLC, United States

    Dr. Kshatriya is author, speaker & medical communications expert with over 25 yrs industry experience. She has published book Recoding Scientific Publishing: Raising the Bar in an Era of Transformation, providing key insights into scientific publishing process. She is founder of Publication Practice Counsel, Truposha LLC, providing medical communication services to pharmaceutical, biotech & medical device companies. Prior to this, she has worked at Novartis Oncology, ALTANA Pharma, Aventis Pharmaceuticals, and DuPont Merck Pharmaceutical Company. She has extensive medical affairs experience, including publications, med education, med info, ad boards, etc, and expertise in corporate policy/SOPs, metrics, compliance & monitoring

  • Monica  Kwarcinski, PharmD

    Monica Kwarcinski, PharmD

    • VP Medical Affairs
    • Purdue Pharma L.P., United States

    Monica Kwarcinski is currently the Vice President of Medical Affairs at Purdue Pharma. In this role Monica oversees Medical Information, MSLs, Clinical Communications, Health Economic and Outcomes Research, Epidemiology, and FDA Postmarketing Requirement studies. Prior to joining Purdue Pharma, Monica held various positions of increasing responsibilities within Abbott Laboratories Medical Affairs Department. She received her PharmD from Creighton University in Omaha, Nebraska followed by a Drug Information Residency University of North Carolina, Chapel Hill and Glaxo. Monica has 25+ years of industry experience and frequently speaks on topics related to industry medical communications compliance and department processes.

  • MaryKate  Lesnevich

    MaryKate Lesnevich

    • Associate Director, Global Scientific Communications, I&I
    • Celgene Corporation, United States

    MaryKate Lesnevich is Associate Director, Global Scientific Communications, I&I at Celgene Corporation. She has over 16 years of experience working in both the medical device and pharmaceutical industry. During that time, MaryKate has primarily focused on peer-reviewed publication planning related to abdominal surgery, dermatology, gastroenterology, neurology, and rheumatology. In her current role, MaryKate leads the global publication teams for neurology and gastroenterology at Celgene. MaryKate has a MS in Clinical Trial Management and is a Certified Medical Publication Professional (ISMPP CMPP™).

  • Jimmie  Overton, PharmD

    Jimmie Overton, PharmD

    • Associate VP, Global Medical Scientific Information and Library
    • Allergan, Inc., United States

    Jimmie Overton, PharmD is the Associate Vice President of Global Medical Scientific Information and Library for Allergan’s Chief Medical Office. His organization is responsible for the global medical information function, the medical science library, and the medical review and approval of promotional material across the Allergan portfolio. Dr. Overton has over 20 years of diverse experience in healthcare, serving in practical, academic, clinical, research, and industry settings. He has held leadership positions in a variety of functions in the pharmaceutical industry serving: Medical Information, Medical Education, Medical Communications, Medical Affairs Operations, Medical Liaison teams, and as Medical Director.

  • Jennifer  Park, PharmD

    Jennifer Park, PharmD

    • Global Medical Information Content Manager
    • Sanofi, United States

    Jennifer Park is a Global Content Manager at Sanofi working in the Consumer Healthcare and General Medicines product portfolios in the Global Medical Information organization. She received her Pharm.D. from Rutgers University. Prior to joining Sanofi, Jennifer was a Medical Information fellow at Janssen and Rutgers.

  • Ankur  Shah, PharmD

    Ankur Shah, PharmD

    • Director, US Medical Information
    • Incyte Corporation, United States

    In his role, he is primarily responsible for the management and oversight of all MI activities, including call center operations, and written content development. In addition, Ankur serves as the primary medical reviewer of promotional and scientific materials, and identifies/implements innovative MI communication channels. Prior to joining Incyte, he was the Director, Medical Information at Sunovion Pharmaceuticals. Prior to joining Sunovion, Ankur spent over 8 years working with the Johnson & Johnson Family of Companies in positions of increasing responsibility within MI and Compliance. Ankur earned his Doctor of Pharmacy degree from the University of CT.

  • Ellen  Whipple, PharmD

    Ellen Whipple, PharmD

    • Director of Medical Communications
    • Med Communications, Inc., United States

    Ellen has been employed with Med Communications, Inc for 9 years. She received both pharmacy degrees from the University of Georgia College of Pharmacy. Prior to her career at Med Communications Ellen practiced clinical pharmacy. Ellen is currently an Assistant Clinical Professor at the University of Georgia College of Pharmacy and a Medical Advisor for the Multiple Sclerosis Foundation. Ellen has 15+ years’ experience in writing and articulating scientific information. During this time, she has lectured to pharmacy students on multiple sclerosis, presented on multiple sclerosis at 30+ medical meetings/advisory boards, published 100+ articles, written advisory board meeting reports, and responded to FDA response letters.

  • Shelby Lynn Biagi, PharmD

    Shelby Lynn Biagi, PharmD

    • Site Engagement Manager
    • UCB Biosciences, Inc., United States

    Dr. Biagi serves as Site Engagement Manager for UCB, Inc. She brings 15 years of experience within the pharmaceutical industry. She has held many memberships and designations over the years including positions with the American Medical Writers Association and the Georgia Pharmacy Association. Dr. Biagi received her PharmD and Drug Information Residency from Mercer University.

  • Dominick L. Albano

    Dominick L. Albano

    • Pfizer, Inc., United States

    Dominick Albano is Vice President, Global Medical Information at Pfizer. He is actively involved in phactMI. He began his industry career at Wyeth Pharmaceuticals as a Drug Information Manager specializing in the neuroscience therapy area. He held positions of increasing leadership and responsibility within Wyeth Global Medical Affairs. During his tenure he oversaw the implementation of a Neuroscience Medical Science Liaison (MSL) group, a Global Medical Communications Neuroscience Collaborative, and a Global Medical Information Leadership Council. Dr. Albano obtained his PharmD degree from the University of the Sciences in Philadelphia and his MBA in Healthcare Administration from Saint Joseph’s University in Philadelphia.

  • Mallory  Alonso

    Mallory Alonso

    • Manager, Medical Affairs
    • US WorldMeds, United States

    Mallory Alonso received her Bachelor of Science and Doctor of Pharmacy degrees from the University of Florida. Mallory joined US WorldMeds as Manager, Medical Affairs in November 2017. In this role, Mallory’s responsibilities include, but are not limited to, overseeing all aspects of Medical Information, managing the Medical Education Grants and Investigator Initiated Research programs, serving as Medical Reviewer for CNS products promotional review, and coordinating Medical Affairs presence at congresses. Mallory is a licensed pharmacist in both Florida and Kentucky. She became a member of DIA in 2018 and looks forward to getting more involved in the organization.

  • Lisa  Ambrosini Vadola, PhD

    Lisa Ambrosini Vadola, PhD

    • Medical Writer and Consultant
    • Whitsell Innovations, Inc., United States

    Lisa Ambrosini Vadola has been a Medical Writer and Consultant at Whitsell Innovations, Inc. since 2013. In this role, she supports clients in the pharmaceutical and biotechnology industries with the preparation of clinical regulatory documents. She has experience in multiple therapeutic areas, including oncology, infectious diseases, dermatology, and inflammatory diseases. Before joining Whitsell Innovations, Inc., Lisa earned a PhD in Chemistry from Columbia University and completed a postdoctoral fellowship in the Laboratory of Chemical Biology and Microbial Pathogenesis at the Rockefeller University.

  • Kevin  Appareti, MBA

    Kevin Appareti, MBA

    • Senior Director, Global Medical Science Liaison
    • Royal Philips, United States

    Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Thought Leadership Program and works across Philips’ businesses, markets, and research to build strong internal and external relationships with key thought leaders and influencers. Kevin partners with internal business, market, and research leaders to develop strategic Key Thought Leader (KTL) engagement programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development in support of Philips meaningful innovations.

  • Teresa S. Armstrong

    Teresa S. Armstrong

    • Advisor, Clinical Document Transparency
    • Eli Lilly and Company, United States

    25 years experience of experience in Scientific Communications including 5 years in Transparency. Active in many external working groups. Certified Editor in the Life Sciences. Loving wife, daughter, sister, and aunt in a wonderful family. Dedicated dog trainer and lover, competing in many dog sports.

  • Leslie  Citrome, MD, MPH

    Leslie Citrome, MD, MPH

    • Editor in Chief, International Journal of Clinical Practice
    • Wiley, United States

    Dr. Citrome is Clinical Professor of Psychiatry & Behavioral Sciences at New York Medical College in Valhalla, NY, and has a private practice in Pomona, NY. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology. Dr. Citrome is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley. He is the author or co-author of over 500 published research reports, reviews, and book chapters in the biomedical literature.

  • David B. Clemow, PhD

    David B. Clemow, PhD

    • Advisor, Scientific Communications Information Strategy
    • Eli Lilly and Company, United States

    David is an Advisor Scientific Communications at Eli Lilly and Company with over 20 years of regulatory, publication, and promotional scientific communications experience in the pharmaceutical industry. His work has included document authoring, team management, operations consulting, clinical research, and medical affairs. David is Chair of the American Medical Writers Association Medical Writing Certification Commission.

  • Fred  Cox, PhD

    Fred Cox, PhD

    • President and Principal of CERES
    • Cox Econometric Research, LLC, United States

    Dr. Cox is currently President and Principal at CERES: Cox Econometric Research, LLC. Prior to that, he has been in HEOR research and leadership positions for 35+ years at the Baltimore Cancer Research Program, the VAMC (Augusta, Ga), GSK, Pfizer, UCB, and Sanofi Genzyme; responsible for therapeutic areas spanning respiratory diseases, oncology, infectious diseases, epilepsy, Parkinson’s disease, Multiple Sclerosis, Lupus, and ophthalmologic diseases. Inaddition, he is affiliate/adjunct faculty at UNC (Chapel Hill), VCU College of Pharmacy, and MCPHS (Boston), and was a founding faculty member at the Campbell University School of Pharmacy. Finally, he has authored 85+ publications within the HEOR area.

  • Michael  Goles, MA

    Michael Goles, MA

    • Director, Office of Medical Professional Development
    • Eli Lilly & Company, United States

    Michael is responsible for the Professional Development of key roles within Lilly's Medical organization. He leads a team to curate interpersonal learning experiences for global MSL/Managers, MAP & CRP/CRS. Michael joined Lilly in July of 2012. His 20+ years of 'learning & development' experience centers around building robust learning portfolios to build strategic capabilities for a variety of organizations in different industries.

  • Evelyn R. Hermes-DeSantis, PharmD

    Evelyn R. Hermes-DeSantis, PharmD

    • Clinical Professor, Ernest Mario School of Pharmacy
    • Rutgers, The State University of New Jersey, United States

    Evelyn Hermes-DeSantis, PharmD, BCPS, is a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey and is the Director of Drug Information Services at Robert Wood Johnson University Hospital. She received her undergraduate and graduate degrees from Rutgers University and completed Specialized Residency in Drug Information Practice at the Medical College of Virginia Hospital in Richmond, Virginia. Over the years she has trained over 25 Specialized Residents in Drug Information Service and has precepted numerous Pharmacy Practice Resident and Clinical Industry Fellows. She is also a board-certified pharmacotherapy specialist.

  • Sarah  Jarvis, MBA

    Sarah Jarvis, MBA

    • Principal
    • ZS, United States

    Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for more than 20 years and has focused exclusively on working with medical affairs clients for the past 10 years at ZS. The Medical Affairs group at ZS has worked with more than 75 companies across pharmaceutical, biotech and medical device companies. Sarah also previously worked at Genentech in a variety of different roles on products that spanned many different therapy areas and phases of the lifecycle.

  • Michelle  Quinlan, PharmD

    Michelle Quinlan, PharmD

    • Associate Director, Medical Information
    • Pfizer, Inc., United States

    Michelle Quinlan is an Associate Director, Medical Information at Pfizer. Dr. Quinlan graduated from St. John’s University College of Pharmacy where she received both her Bachelor of Science and Doctor of Pharmacy degrees. Dr. Quinlan has several years of experience working within the pharmaceutical industry. Prior to joining Pfizer, Dr. Quinlan practiced pharmacy in both the community and hospital settings.

  • Sian  Ratcliffe, PhD

    Sian Ratcliffe, PhD

    • Vice President, Head of Medical Writing
    • Pfizer Inc, United States

    In her role as Head of Medical Writing, Dr Siân Ratcliffe leads a large global team of writers and quality reviewers engaged in Protocol, Clinical Study Report, Clinical Trial Disclosure and Clinical Regulatory Submission document authorship supporting all therapeutic areas and phases of development at Pfizer. Siân brings >18 years biopharmaceutical development experience in leadership roles across the business in Drug Safety R&D, Clinical Development, Safety and Risk Management, as well as Regulatory Affairs. Prior to joining Pfizer, Siân worked as a freelance editor for the Elsevier Trends Journals. Siân has a PhD in Pharmacology from the University of Cambridge where she also held post-doctoral research and academic posts.

  • Mary K. Sendi, PharmD

    Mary K. Sendi, PharmD

    • MI Regional Lead North America
    • Pfizer Inc, United States

    Mary is the Regional North America Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.

  • Susan  Shaffer, PharmD, MBA

    Susan Shaffer, PharmD, MBA

    • Head of Global Medical Capabilities, Respiratory
    • AstraZeneca, United Kingdom

    Susan Shaffer has 20+ years of experience in Med Affairs and is currently the Head of Respiratory Medical Capabilities in Global Medical Affairs at AstraZeneca. She is responsible for leading the Global MSL Excellence, Global Publications, Global Medical Information, Global Medical Training, and Global Patient Engagement teams within the Respiratory Therapeutic Area. She received her PharmD from the University of Maryland and MBA from Saint Joseph’s University. Susan recently returned from a three-year international assignment in the UK, working as the Head of Global MSL Excellence. Prior to this role, Susan has held Med Affairs leadership roles within Field Med Affairs, Med Strategy & Operations, Med Info, and Med Education.

  • Larry  Singer, JD, MBA, RPh

    Larry Singer, JD, MBA, RPh

    • Senior Corporate Counsel & Deputy Global Data Protection Officer
    • Syneos Health, Inc., United States

    Larry Singer is Senior Corporate Counsel & Deputy Data Protection Officer at Syneos Health, Inc. Attorney Singer has extensive experience in global and domestic data privacy laws and is responsible for the execution of the Data Privacy Program at Syneos.

  • Darren  Taichman, MD, PhD

    Darren Taichman, MD, PhD

    • Executive Deputy Editor
    • Annals of Internal Medicine, United States

    Dr. Taichman is the Executive Editor of the Annals of Internal Medicine and Vice President of the American College of Physicians. He is an Adjunct Professor of Medicine at the University of Pennsylvania where he practices Pulmonary and Critical Care Medicine. Dr. Taichman also serves as Secretary of the International Committee of Medical Journal Editors. He earned his MD and PhD from the University of Pennsylvania, completed Internal Medicine residency training at the Beth Israel Hospital, Harvard Medical School, Pulmonary and Critical Care Fellowships at the Hospital of the University of Pennsylvania and research / post-doctoral fellowships at the Brigham and Women's Hospital, Boston and the Children's Hospital of Philadelphia.

  • Jim R. Wilkinson, PhD

    Jim R. Wilkinson, PhD

    • Associate Director, Medical Writing
    • Amgen, Inc., United States

    Jim Wilkinson is an Executive Director of Global Medical Affairs at Amgen with over 17 years of experience in Medical Communications, Medical Information, and Medical Science Liaisons (MSLs). His experience includes managing Departments focused on global scientific content, contact centers, publications, congresses, scientific advisory boards, creation of MSL resources, and Promotional Review Committees across multiple therapeutic areas. Jim has managed U.S. MSL teams including scientific engagement plans for opinion leaders, disease state and product discussions, clinical research and formulary support, and has accountabilities for overall global MSL strategies at Amgen.

  • Emily  Costerison, PharmD

    Emily Costerison, PharmD

    • Principal Medical Science Director
    • Genentech Inc., United States

    Emily Costerison is Principal Medical Science Director within US Medical Affairs at Genentech. She has worked at Genentech since 2007 with a focus on communicating clinical information to managed care organizations. Emily received her Doctor of Pharmacy degree from the University of Washington. She also completed a Pharmacy General Practice Residency and Drug Information Residency at Stanford Hospital & Clinics.

  • Michael  Abbadessa, PharmD

    Michael Abbadessa, PharmD

    • Founder and Cheif Executive Officer
    • OpX Insights, Inc., United States

    Dr. Abbadessa has over 15 years in the pharma industry across all functions within Medical Affairs including field teams and home office senior leadership roles. His most recent position was the Sr Director of Innovation and Strategy for Medical Affairs at a top 20 Pharma company. In addition, he has 17 years of acute care hospital practice and has been a medical leader and managed diverse teams, in various settings for most of his career. Mike’s value proposition is leading and developing teams to optimize a team’s performance to the highest level through quality improvement, continuous learning, and constant innovation. He is an ideator and passionate about people development, and motivating others to achieve their goals.

  • Jamie  Arvizu, MD, MPH

    Jamie Arvizu, MD, MPH

    • Head of Medical Affairs LATAM
    • Ultragenyx, United States

    Dr. Jaime Arvizu is a senior executive pharmaceutical physician and VP of Medical Affairs with 27+ years of global leadership experience. He has built and led MA teams, with growth strategies which lay the foundation for patient-centered medical excellence at country, region and global levels. Jaime is passionate about transforming the standards of medical care and leaving a legacy of better living for patients with rare and debilitating disease. Dr. Arvizu’s expertise include extensive portfolio management initiatives across multiple TAs, spanning strategic product development, medical education, field-based medical teams (MSLs), disease management and other patient programs.

  • Behtash  Bahador, MS

    Behtash Bahador, MS

    • Associate Director, Relationship Management and Development
    • CISCRP, United States

    Behtash Bahador is an Associate Director at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into the process of clinical research, and always keeping the needs of patients, participants and the public at the forefront of his work.

  • Dawn  Beach, PharmD

    Dawn Beach, PharmD

    • Medical Information Director, Respiratory US Medical Information
    • GlaxoSmithKline, United States

    Dawn Beach, Pharm D is a Director of Medical Information at GlaxoSmithKline (GSK) and has been in the pharmaceutical industry for 9 years. Prior to joining GSK, she spent 11 years as a hospital clinical pharmacist. Currently, she leads the payer and policy maker strategy for U.S. Medical Information. Additionally, she leads a team to deliver traditional and innovative medical content. In this role, she works across the matrix to understand and ensure medical information content aligns with the medical value story, voice of the customer, and medical engagement plans.

  • Elizabeth  Brown, PMP

    Elizabeth Brown, PMP

    • Managing Medical Writer
    • Merck & Co., Inc., United States

    Elizabeth Brown is a Managing Medical Writer at Merck. She brings a versatile trifecta of qualifications to medical writing including a strong science background (B.S. Biochemistry, Purdue University), a regulatory interest (M.S. Regulatory Affairs, Temple University), and a project management focus (PMP certification). Elizabeth started in the pharmaceutical industry nearly 2 decades ago, first as a laboratory scientist and then continuing into clinical research in infectious disease. She became one of the pioneers of Merck’s new Medical Writing department in 2015, and since then, has truly enjoyed writing, managing, and leading teams to create efficient, effective, and quality documents.

  • Julia  Forjanic-Klapproth, PhD

    Julia Forjanic-Klapproth, PhD

    • President/Senior Partner
    • Trilogy Writing & Consulting, Germany

    After receiving her PhD in developmental neurobiology, Julia started her career as a medical writer in the regulatory group at Hoechst Marion Roussel (later Sanofi) in 1997. Since then she has been president of the European Medical Writers Association (EMWA) twice and is an active speaker and workshop leader in the area of medical writing. In 2002, Julia co-founded Trilogy Writing & Consulting, a company specialised in providing regulatory medical writing. In addition to managing the company as President/Senior Partner, she writes a wide array of clinical documents and is specialised in the clinical parts of CTD submission dossiers.

  • Ilya  Gipp, MD, PhD

    Ilya Gipp, MD, PhD

    • Oncology Solutions Executive
    • Philips HeathTech, United States

    Ilya Gipp is the Oncology Executive in Philips Heathtech, representing company for Oncology products portfolio in North America. He has taken this position as of August 2017 relocating from the Netherlands, where he was responsible for MR Therapy and Radiation Oncology Solutions business development of Royal Philips globally. Ilya has a strong clinical, scientific, business development and marketing background in Diagnostic Imaging and Oncology he has an MD in diagnostic radiology and a PhD in neuroradiology. He is continuing to practice diagnostic radiology remotely for the chain of clinics in the South and East of Europe.

  • Hilary  Mandler, PharmD

    Hilary Mandler, PharmD

    • Director, Pharmaceutical Industry and Education Fellowship Program
    • University of the Sciences, United States

    Hilary D. Mandler, PharmD is currently Director, Pharmaceutical Industry and Education Fellowship Program at the Philadelphia College of Pharmacy/USciences. Mandler’s pharmacy career has spanned across clinical practice, academia, clinical research and industry. 15+ years industry experience in medical affairs, she was responsible for hiring the first MSL organization at Shire, then expanding the organization to provide MSL leadership across multiple therapeutic areas. Hilary is responsible for managing eight fellows within 4 unique companies. She is responsible for fellowship recruitment and marketing, industry partnerships, budget management, and mentorship to guide professional growth and leadership capabilities of each fellow.

  • Lori  Mouser, PharmD

    Lori Mouser, PharmD

    • Global Head, Medical Science Liaisons
    • Roche, Switzerland

    Lori Mouser brings over 15 years of experience in leading Medical Science Liaison teams to her role as Global Head of MSLs for Roche Product Development-Medical Affairs. Lori thrives on collaborating across teams to find clever approaches to challenging situations.  She strives to genuinely understand what each individual brings to a project so that the outcome of the work can be effective and meaningful. After an academic career as an Associate Professor in Clinical Pharmacy at Washington State University, Lori joined Aventis (Sanofi) Pharmaceuticals as an MSL. She quickly gravitated to managing MSL teams and remained at Sanofi for 13 years. In 2012, she moved to Genentech as an MSL leader in BioOncology and joined the Roche family.

  • Ghiesla  Nel

    Ghiesla Nel

    • Head of Global Medical Information
    • Ipsen Biopharm Ltd, United Kingdom

    Ghiesla Nel, B Pharm, is Head of Global Medical Information at Ipsen. Ghiesla started her career in GSK in 2005 and since has gained a broad experience in both Medical Information and Pharmacovigilance in small, medium and large Pharma. Ghiesla has experience in setting up local (and now global) Medical Information functions, sourcing and implementing a global medical information database as well as successfully outsourcing first line medical information services. In the middle of her Medical Affairs career Ghiesla did a 4-year tenure in marketing which harnessed her strategic thinking and brought unique perspectives of the value of Medical Information.

  • Anthony  Page

    Anthony Page

    • Co-Founder, Chief Executive Officer
    • Voxx Analytics, United States

    Tony has over 30 years of experience creating and delivering analytical products and services. In his past career in the U.S. intelligence community, he directed intelligence operations in various strategic analysis organizations in the US and abroad. Subsequently, Tony used his insight to apply intelligence methodologies to pharmaceutical industry problems. Over the past decade, he has developed the novel technologies that are now Voxx Analytics, bringing rigorous advanced analytics to bear on engagement-related challenges. Tony has an MS from National Intelligence University and an MBA from the Peter F. Drucker School of Business.

  • Patricia  Pagnotta, MSN

    Patricia Pagnotta, MSN

    • Nurse Practitioner
    • Neurology Associates, United States

    Patricia Pagnotta, APRN, MSN, MSCN, CNRN Graduate of Towson State University, Post Graduate work done at University of Maryland and University of Central Florida. Works at the MS Center of Greater Orlando, a division of Neurology Associates in Maitland, FL. Active in the MS providing direct care, performing research and educating peers and patients. Has spoken nationally and internationally. Published in Peer Reviewed Journals. Current President of the International Organization of MS Nurses (IOMSN)

  • Patrick  Reilly, MS, MSc

    Patrick Reilly, MS, MSc

    • CEO
    • phactMI, United States

    Patrick Reilly has more than 30 years experience in the pharmaceutical industry. He is currently the CEO for phactMI, a non-profit organization comprised of 28 pharma companies across the industry with a mission to raise awareness, ensure credibility, and facilitate easy access to medical information. Prior to leading phactMI, Patrick was the head of global Medical Information at BMS. Patrick's industry experience in pharma includes leadership roles in R&D clinical operations and across several Medical Affairs functions including post marketing clinical trials, field medical, and medical communication. Patrick is a long-time member of DIA, as well as ISMPP, MAPs, and ASAE.

  • Ina  Shah, PharmD

    Ina Shah, PharmD

    • Director
    • Allergan Plc, United States

    Ina Shah, PharmD, RPh Director, Medical Information – Allergan Ina is a pharmaceutical professional with over 25 years of US and global experience in Medical/Scientific Communications, Drug Safety/Pharmacovigilance and Clinical Research. She is currently responsible for the Medical Information function at Allergan and her department delivers high-quality medical information and develops global content for requests from healthcare professionals and patients. Ina is passionate about Medical Affairs and its role in supporting customers to ensure safe and effective use of medicines. In addition to Allergan, Ina has previously managed multi-functional teams and held roles of increasing responsibility at Hoffmann La Roche.

  • Catherine  Skobe, MPH

    Catherine Skobe, MPH

    • Senior Director, Publications Management Team Lead
    • Pfizer, Inc., United States

    Catherine W. Skobe MPH, MT(ASCP) Catherine is the Publications Management Team Leader at Pfizer. Prior to Pfizer, she worked at IntraMed, Becton Dickinson, and at UNC Hospitals. Catherine is a member of ISMPP and is currently Chair-Elect. She served on the Ethics committee and co-founded the Social Media and Web-based Metrics Working Group. She earned a BS in Medical Technology from the University of North Carolina at Chapel Hill and is certified as a Medical Technologist from the American Society of Clinical Pathology. Catherine received her MPH with a concentration in Community Health Education from Hunter College.

  • Sandra  Wainwright

    Sandra Wainwright

    • Executive Director
    • Merck Canada Inc., Canada

    Dr. Wainwright received her Ph.D. in Experimental Medicine from McGill University. Dr. Wainwright has 25 years of experience in the pharmaceutical industry in both Regulatory Affairs and Marketing and is currently Executive Director, Regulatory Affairs at Merck Canada. Dr. Wainwright is an Executive of the Regulatory Affairs Committee of Innovative Medicines Canada and has led the industry working group for Legislative and Regulatory Modernization since 2006. Recently, Dr. Wainwright was a member of the Health Canada Stakeholder Reference Group for the implementation of the public release of clinical information.

  • James  Walter, PhD

    James Walter, PhD

    • National Team Leader, Cardiometabolic RSDs, US Medical Affairs
    • Merck Research Labs, United States

    James D. Walter, PhD has over 20 years of leadership experience in the pharmaceutical industry in support of clinical development and medical affairs. He was worked across several therapeutic areas including cardiovascular, respiratory & allergy, thrombosis, etc.

  • Isabelle C. Widmer, DrMed

    Isabelle C. Widmer, DrMed

    • Medical Affairs Consultant
    • elytra GmbH, Switzerland

    Isabelle Widmer, MD is a life science consultant based in Europe. Isabelle supports teams in both Fortune 500 companies and biotech to deliver global transformation programmes in Medical Affairs and Med Info. Combining an entrepreneurial mindset, analytical and project management skills with the ability to design and implement tailored solutions, Isabelle takes pride in proposing pragmatic, sustainable and cost-effective solutions. A published author, frequent conference presenter, recent Programme Director at Basel University in postgraduate education in pharmaceutical medicine and a Program Committee member for the DIA Annual European Medical Information and Communications Meeting she is also passionate about continuing education.

  • Lisa  Zimmerman, MS

    Lisa Zimmerman, MS

    • President
    • Axis Pharma, United States

    Lisa ZImmerman is an accomplished professional with a proven track record of success in Clinical Operations and Development, Regulatory Affairs, Regulatory Compliance and Quality Assurance. As a 26 year pharmaceutical veteran she has a broad experience in many areas of drug, device, and biologic development and was instrumental in bringing three three drugs to market for Pozen Pharmaceuticals (Treximet, Vimovo, and Yosprala). She has held leadership roles at ClinTrials Research, DCRI, POZEN, and Pernix Therapeutics. She now heads her own company that focuses on helping small biotech companies on navigating the pathways for drug, biologic and device development around the world.

  • Lisa  Chamberlain-James, PhD

    Lisa Chamberlain-James, PhD

    • Senior Partner
    • Trilogy Writing & Consulting, United Kingdom

    After receiving her PhD in Pathology, Lisa started her career as a medical writer in the pharmaceutical industry at Napp Pharmaceuticals in 2000. In 2011, she joined Trilogy Writing & Consulting, a company specialised in providing medical writing. In addition to company management activities as Senior Partner and CEO, she continues to undertake client projects, writing a wide array of clinical documents and with a special interest in drug safety and patient information. She has experience of both communications and regulatory medical writing, and is also an experienced trainer of medical writers, regularly running and assessing workshops for the European Medical Writers Association (EMWA).

  • Mick  Foy

    Mick Foy

    • Head of Pharmacovigilance Strategy
    • Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

    Mick Foy is Head of Pharmacovigilance Strategy at the MHRA. Among is responsibilities is the running of the UK ADR reporting system and signal detection activities. Mick is also leads the MHRA's work with WHO and the Bill and Melinda Gates Foundation on capacity building in low and middle income countries. Mick is the current Chair of the MedDRA Management Committee and is a board member of the Uppsala Monitoring Centre.

  • Andrew  Gazo, PharmD, MS

    Andrew Gazo, PharmD, MS

    • Head of CHC Global Content, Medical Information
    • Sanofi, United States

    Andrew Gažo is currently Head of Global Content for Consumer Healthcare in the Sanofi Medical Information Department and is a Board member of phactMI. Andrew has been active in all aspects of Medical Information, including content globalization, compliance monitoring, business development & contracting, launch preparation & crisis management, and creation & management of payer materials, including AMCP pre- and post approval dossiers. Andrew currently leads a team who provide global medical information customers for the consumer healthcare and established medicines drugs and devices. Andrew joined the Sanofi Medical Information Department in 1998, and has supported products in a many diverse therapeutic areas.

  • Avikk S Ghose, MBA

    Avikk S Ghose, MBA

    • CEO
    • kernel, United States

    Avikk is co-founder and CEO of kernel. Previously, he directed strategic mobile initiatives at Intuit where his team was responsible for product strategy, mergers & acquisitions and best-practice innovations in the wireless ecosystem. Before Intuit, Avikk was vice president, marketing and business development at Mercora and worked in corporate development at RealNetworks. Avikk serves on the board of trustees at the Ghose Foundation. He is on the board of advisors at Virtual Mobile Technologies (Pty) Ltd in Cape Town, South Africa and is a senior advisor at Endeavor. Avikk received an undergraduate degree in economics from the University of Washington and an MBA from New York University.

  • Jully  Kim, PharmD

    Jully Kim, PharmD

    • Director, Global Medical Information
    • Celgene Corporation, United States

    Jully Kim, PharmD is a Director in Global Medical Information at Celgene where she oversees a team primarily responsible for medical review of promotional materials, inquiry insight generation, medical congress support, Compendia submissions and other related business initiatives in Hematology/Oncology. Prior to joining Celgene, Jully was at Bristol-Myers Squibb where she gained experiences in Medical Information, Medical Strategy and Sales Training across Neuroscience, Virology, Immunoscience and Cardiovascular. Jully completed her Rutgers Pharmaceutical Industry Post-Doctoral Fellowship at Bristol-Myers Squibb Medical Information and received her Doctor of Pharmacy from Rutgers, Ernest Mario School of Pharmacy.

  • Frank  Lock

    Frank Lock

    • Director, Information Center
    • AstraZeneca Pharmaceuticals, United States

    Frank Lock is an experienced leader skilled in contact center management, customer and client interaction, strategy and operations, and managing people, suppliers, processes, information technology, and budget. He has worked in the pharmaceutical industry for many years. Frank currently works as Director of the Information Center at AstraZeneca Pharmaceuticals in Wilmington Delaware. He holds a Bachelor of Electrical Engineering degree from the University of Delaware, and an MBA degree from Penn State University.

  • Chris  Maxwell

    Chris Maxwell

    • Patient Advocate, United States

    Chris Maxwell served 19 years as lead pastor in Orlando, Florida, and is in his thirteenth year as Campus Pastor and Director of Spiritual Life at Emmanuel College. He almost died of encephalitis in 1996, and now lives with severe brain damage and epilepsy. Chris has hosted tv and radios shows, and speaks in conventions, conferences, churches, and schools around the world. He is the author of nine books, including “Pause,” “Underwater,” and his latest, “a slow and sudden God: 40 years of wonder.” Chris and his wife Debbie have three sons and five grandchildren. Visit him at www.chrismaxwell.me

  • Eileen E. Navarro Almario, MD, MS, FACP

    Eileen E. Navarro Almario, MD, MS, FACP

    • Lead Medical Officer, OCS, OTS, CDER
    • FDA, United States

    Eileen Navarro, MD, FACP serves as lead in the Office of Computational Science which implements regulatory science (tools, standards and analytic approaches) to support a modern regulatory review process.

  • Chirayu  Parikh, PharmD

    Chirayu Parikh, PharmD

    • Regional Medical Liaison
    • Novo Nordisk Inc., United States

    Dr. Parikh is the Regional Medical Liaison at Novo Nordisk with over 10 years of experience spanning community pharmacy practice, pharmacy district leadership, pharmacovigilance, and medical information. He is currently responsible for management and dissemination of med info to both internal and external stakeholders for pipeline and marketed diabetes and obesity compounds. Dr. Parikh has managed the development of digital communication channels to disseminate health economic outcomes research (HEOR) data and clinical trial information while leveraging data mining tools to collect analytics and generate user insights. He earned his Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers University.

  • Jennifer  Slade, PharmD

    Jennifer Slade, PharmD

    • Senior Director, Global Lead MSLs
    • Novartis Pharmaceuticals, United States

    Jennifer Slade, PharmD is an Executive Director at Novartis Pharmaceuticals in Oncology Global Medical Affairs, Scientific Engagement & Communications. In this role, she is responsible for developing and communicating MSL Strategic Plans, HCP Engagement, Medical Information and Global Scientific Communications for the Solid Tumor and Rare Disease Franchise. With over 18 years of experience in industry, Jennifer has held various roles in Global Clinical Development, US Medical (including MSL, MSL Strategy, MSL Training) and Global Medical Affairs in several therapeutic areas. Jennifer received her Doctor of Pharmacy from Purdue University.

  • William A. Soliman, PhD

    William A. Soliman, PhD

    • President
    • ACMA, United States

    Dr. William Soliman is currently the President/CEO of the Accreditation Council for Medical Affairs (ACMA). He has several years of experience in the pharmaceutical and biotechnology industry across. He has held key positions where he was instrumental in launching a variety of innovative platforms expanding the role of medical affairs across the industry. He has been featured in Forbes, ABC News and other media outlets discussing pharma with a particular focus on medical affairs. He earned his BA from New York University and his PhD from Columbia University.

  • Debra  Bello, PhD, RN

    Debra Bello, PhD, RN

    • Director, Specialty Therapies, Global Medical Information
    • AbbVie, Inc., United States

    Debra Bello is currently the Director, Global Medical Communications at AbbVie. She has >25 years of healthcare experience in clinical, research and industry settings. She is a registered nurse and holds a doctorate of nursing from the University of Illinois, Chicago. She began her industry career at Baxter Healthcare Corporation and gained increasing roles and responsibilities in the Medical Affairs and Medical Information functions. Debra has been with AbbVie for 2.5 years and is now leading the Global Medical Communications-Specialty Team which includes medical information and publications.

  • Annamaria  Crisan, MS, MSc

    Annamaria Crisan, MS, MSc

    • Pfizer, Canada

    Annamaria Crisan BPharm, MSc Annamaria is currently the Digital Director and member of North America Oncology team in Medical Information at Pfizer. She has been with Pfizer for 9 years occupying various roles with oncology medical information team. Most recently she took on an additional role as Digital Director for North America in Medical Information. In this capacity she is overseeing some of the digital initiatives in medical information, in addition to the oncology breast cancer products support. Annamaria received her Bachelor of Science degree in Pharmacy in Romania and her Master of Science degree in Pathology and Cellular Biology from University of Montreal.

  • Hemali  Patel, PharmD, RPh

    Hemali Patel, PharmD, RPh

    • Medical Information Therapeutic Manager
    • Novo Nordisk Inc., United States

    Hemali Patel is a Medical Information Manager at Novo Nordisk Inc. In her current role, she is responsible for maintaining/creating standard response documents to provide medical information to external and internal stakeholders and providing insights to cross functional teams. Prior to joining the team as a manager less than a year ago, Hemali completed her post-doctoral fellowship at Novo Nordisk Inc. gaining experience in Medical Information and Medical Affairs. She completed her PharmD at the University of the Sciences in Philadelphia. Outside of work, she loves to travel, try new foods and spend time with her family and friends.